Skip to main content
. 2021 Mar 16;9(3):305. doi: 10.3390/biomedicines9030305

Table 2.

A clinical trial of nanomaterial-mediated PTT for cancer therapy.

Name
(Company)		 Particle Type Indication Clinical State on Clinical Trial.Gov Identifier
AuroLase ®
(Nanospectra Biosciences)		 PEG-coated silica-gold nanoshells (AuroShell ®) for NIR-facilitated thermal ablation Solid primary and/or metastatic lung tumors 2016
(NCT01679470-
terminated)
Refractory and/or recurrent tumors of the head and neck 2017
(NCT00848042-
completed)
Neoplasms of the prostate 2019
(NCT02680535-
active, not recruiting)
2020
(NCT04240639-
recruiting)